TRANSPLANT IMMUNOMODULATION BY ALLOCHIMERIC MOLECULES
TRANSPLANT IMMUNOMODULATION BY ALLOCHIMERIC MOLECULES
批准号:
7156937
负责人:
Rafik MARK GHOBRIAL
金额:
$25.3万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-07-01 至 2008-12-31
关键词:
AbbreviationsAddressAllograft ToleranceAllograftingAlloimmunizationAntigensAutoradiographyCD4 Positive T LymphocytesCellsChronicClassCoupledCyclosporineCyclosporinsDataDendritic CellsDetectionDevelopmentEngineeringEpitopesEventExhibitsFoundationsGenerationsGenesGrowth FactorHepaticHistocompatibility Antigens Class IIgG1ImmuneImmune responseIn VitroIsoantibodiesLabelLocalizedMajor Histocompatibility ComplexMapsMediatingModelingMononuclearOrganPathway interactionsPeptide MappingPhysiologic pulsePolymerase Chain ReactionPopulationProcessProteinsPulse takingRattusRecombinantsResearch PersonnelSequence AnalysisSiteSpecificitySpliced GenesT-Cell ReceptorT-LymphocyteTestingTransplant RecipientsTransplantationTransplantation ToleranceUrsidae FamilyVenousbasecell typeheart allograftimmunogenicimmunoregulationin vivoinnovationinsightnovelprogramsresponse
中文摘要
我们寻求开发一种临床适用的策略来诱导“真正的”移植耐受治疗
英文摘要
We seek to develop a clinically applicable strategy to induce "true" transplantation tolerance treated with
allochimeric Class I MHC molecules. Our novel findings in a rat cardiac allograft model provide the foundation of
this proposal. We hypothesize: (i) allochimeric-induced tolerance is applicable to genetically diverse allograft
recipients; (ii) allochimeric molecules modulate the immune response b y indirect presentation; (iii) a Ilochimeric
molecules generate unique regulatory T cells with distinctive functional and TcR allospecificities. We propose:
1. To Define the Requirements of Different AIIochimeric Molecules to Induce Tolerance. Multiple allochimeric
molecules, in different strain combinations, will be constructed to define critical immunogenic epitopes in the
polymorphic regions of class I MHC. AIIochimeric molecules that display donor-dominant epitopes on recipient-
class I antigens will be tested for their ability to induce "true" chronic rejection-free tolerance.
2. To Analyze AIIoimmune Modulation by Indirect Presentation of Allochimeric [_lh___U]-RT1.aA Class I MHC
Molecules. Fine mapping of immunogenic/cryptic self-epitopes that are critical for allograft tolerance will be
_erformed. Indirect allochimeric deviation of T cell responses will be addressed by employing host or donor-type
dendritic cells that have been pulsed in vitro with donor wild-type or [Ohh_U]-RT1.Aa molecules. AIIochimeric protein
labeling and detection will localize the site and cell-type involved in allochimeric processing and presentation.
Requirement of 'immature vs mature' hepatic DC for allochimeric tolerance induction will be investigated in vivo by
functional stimulation of DC matudty and allostimulatory capacity using FIt3L, a heamatopoietic growth factor, to
potentially abrogate indirectly induced tolerance following intra-portal allochimeric delivery.
3. To Characterize the Unique Population of Requlatory T Cells Induced by Indirect Allorecognition. We will
perform in vivo and ex vivo phenotypic and functional characterization of regulatory T cells. Allochimeric generation
of regulatory T cells, a possible key tolerogenic mechanism in this model, will be probed in vitro by studying
immature hepatic dendritic cells that indirectly present allochimeric molecules to CD4+ T cells. Third, in vivo
analysis of chronic rejection coupled with CDR3 spectrotyping, immunoscope and sequence analysis of
allochimedc-induced clonally-restricted regulatory T cells will define unique T cell functional specificities and the
influence of allochimeric sequence on the allospecific TcR repertoire>
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Donor MHC class I peptides in conjunction with self-epitopes induce donor-specific tolerance in a dose-dependent manner but unable to abrogate chronic rejection.
供体 MHC I 类肽与自身表位结合以剂量依赖性方式诱导供体特异性耐受,但无法消除慢性排斥。
DOI:
10.1016/j.transproceed.2005.02.114
发表时间:
2005
期刊:
Transplantation proceedings.
影响因子:
--
作者:
[Semiletova,NV, Shen,X-D, Feldman,DM, Busuttil,RW, Kupiec-Weglinski,JW, Ghobrial,RM]
通讯作者:
Ghobrial,RM
Intragraft gene expression profile associated with the induction of tolerance by allochimeric MHC I in the rat heart transplantation model.
移植物内基因表达谱与大鼠心脏移植模型中异源嵌合 MHC I 诱导耐受相关。
DOI:
10.1002/dvg.20574
发表时间:
2010
期刊:
Genesis (New York, N.Y. : 2000)
影响因子:
--
作者:
[Lisik,Wojciech, Gong,Yongquan, Tejpal,Neelam, Skelton,ThomasS, Bremer,EricG, Kloc,Malgorzata, Ghobrial,RafikM]
通讯作者:
Ghobrial,RafikM
DOI:
10.1016/j.trim.2010.06.009
发表时间:
2010-08
期刊:
Transplant immunology
影响因子:
1.5
作者:
[Skelton TS, Tejpal N, Gong Y, Kloc M, Ghobrial RM]
通讯作者:
Ghobrial RM
Allochimeric molecules and mechanisms in abrogation of cardiac allograft rejection.
同种异体嵌合分子和消除心脏同种异体移植排斥反应的机制。
DOI:
10.1016/j.healun.2011.01.715
发表时间:
2012
期刊:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
影响因子:
--
作者:
[Skelton,TSpencer, Tejpal,Neelam, Gong,Yongquan, Kubiak,JacekZ, Kloc,Malgorzata, Ghobrial,RafikM]
通讯作者:
Ghobrial,RafikM
DOI:
10.1371/journal.pone.0008020
发表时间:
2009-12-02
期刊:
PloS one
影响因子:
3.7
作者:
[Lisik W, Tejpal N, Gong Y, Skelton TS, Ganachari M, Bremer EG, Kloc M, Ghobrial RM]
通讯作者:
Ghobrial RM
共 6 条
4/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
-
批准号:10711018
-
项目类别:
-
资助金额:$32.48万
-
财政年份:2023
-
负责人:Rafik MARK GHOBRIAL
-
依托单位:
TRANSPLANT IMMUNOMODULATION BY ALLOCHIMERIC MOLECULES
-
批准号:6760900
-
项目类别:
-
资助金额:$26.69万
-
财政年份:2003
-
负责人:Rafik MARK GHOBRIAL
-
依托单位:
TRANSPLANT IMMUNOMODULATION BY ALLOCHIMERIC MOLECULES
-
批准号:6999763
-
项目类别:
-
资助金额:$26.06万
-
财政年份:2003
-
负责人:Rafik MARK GHOBRIAL
-
依托单位:
TRANSPLANT IMMUNOMODULATION BY ALLOCHIMERIC MOLECULES
-
批准号:6679033
-
项目类别:
-
资助金额:$13.34万
-
财政年份:2003
-
负责人:Rafik MARK GHOBRIAL
-
依托单位:
TRANSPLANT IMMUNOMODULATION BY ALLOCHIMERIC MOLECULES
-
批准号:6838746
-
项目类别:
-
资助金额:$26.69万
-
财政年份:2003
-
负责人:Rafik MARK GHOBRIAL
-
依托单位:
ADLDT: An Opportunity to Expand the National Donor Pool
-
批准号:7276431
-
项目类别:
-
资助金额:$3.05万
-
财政年份:2002
-
负责人:Rafik MARK GHOBRIAL
-
依托单位:
ADLDT: An Opportunity to Expand the National Donor Pool
-
批准号:6660317
-
项目类别:
-
资助金额:$21.04万
-
财政年份:2002
-
负责人:Rafik MARK GHOBRIAL
-
依托单位:
ADLDT: An Opportunity to Expand the National Donor Pool
-
批准号:7120588
-
项目类别:
-
资助金额:$28.09万
-
财政年份:2002
-
负责人:Rafik MARK GHOBRIAL
-
依托单位:
ADLDT: An Opportunity to Expand the National Donor Pool
-
批准号:7617327
-
项目类别:
-
资助金额:$7.21万
-
财政年份:2002
-
负责人:Rafik MARK GHOBRIAL
-
依托单位:
ADLDT: An Opportunity to Expand the National Donor Pool
-
批准号:6945885
-
项目类别:
-
资助金额:$33.71万
-
财政年份:2002
-
负责人:Rafik MARK GHOBRIAL
-
依托单位:
ADLDT: An Opportunity to Expand the National Donor Pool
-
批准号:6803451
-
项目类别:
-
资助金额:$23.11万
-
财政年份:2002
-
负责人:Rafik MARK GHOBRIAL
-
依托单位:
海外基金